Organs-on-a-chip models for biological research
Open accessAbstract
We explore the utility of bioengineered human tissues-individually or connected into physiological units-for biological research. While much smaller and simpler than their native counterparts, these tissues are complex enough to approximate distinct tissue phenotypes: molecular, structural, and functional. Unlike organoids, which form spontaneously and recapitulate development, "organs-on-a-chip" are engineered to display some specific functions of whole organs. Looking back, we discuss the key developments of this emerging technology. Thinking forward, we focus on the challenges faced to fully establish, validate, and utilize the fidelity of these models for biological research.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Organs-on-chips are perfused microfluidic devices with engineered or miniaturized tissues linked by 3D microchannels to mimic organ functions, biomechanics and pathophysiological responses.
“OoCs are perfused microfluidic platforms that contain bioengineered or miniaturized tissues or organs interconnected by 3D microchannels to simulate the in vivo functions, biomechanics and (patho)physiological responses of organs6,52–54.”
From Human disease models in drug development (2023) · cites this paper as [53]
The Introduction describes organs-on-chips as engineered tissue constructs that reproduce selected organ functions using physical signals and fabricated channels. But it says these constructs are not mini-organs, and the section on combining single-organ models describes several ways to connect them—not necessarily 3D microchannels. The claim therefore overstates what all organs-on-chips contain. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Langer, R., & Vacanti, J. P. (1993) · Science · doi:10.1126/science.8493529 · Cited by 9,893 · cited 1× · see citing works
“The field of tissue engineering, created in the late 1980s, was defined as ‘‘the application of the principles and methods of engineering and life sciences toward the fundamental understanding of structure-function relationships in normal and pathologic mammalian tissues and the development of biological substitutes t…”
BackgroundReconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 3× · see citing works
“Barrier function Barrier function was the first one to be established using an OOC approach in a lung-on-a-chip device (Huh et al., 2010) (Figure 4A) that can recapitulate many epithelial barriers.”
BackgroundInfluentialThe human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449 · see citing works
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196 · cited 1× · see citing works
“Organoids naturally form into multicellular structures that provide faithful models for studying early development and some diseases (Clevers, 2016), in contrast to OOCs that utilize bioengineering tools to assemble matured tissue constructs that display distinct organ functions.”
BackgroundControl of Stem Cell Fate by Physical Interactions with the Extracellular Matrix
Guilak, F., Cohen, D. M., Estes, B. T., Gimble, J. M., Liedtke, W., & Chen, C. S. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.06.016 · Cited by 1,837 · cited 1× · see citing works
“culture, multiple cell types) (Guilak et al., 2009; Ronaldson-Bouchard et al., 2018; Zhao et al., 2019); and (3) bioactivation, by activating certain pathways (via endogenous signaling, environmental stimuli, and transcriptomic factors).”
BackgroundMultivascular networks and functional intravascular topologies within biocompatible hydrogels
Grigoryan, B., Paulsen, S. J., Corbett, D. C., Sazer, D. W., Fortin, C. L., Alexander, Z., Greenfield, P. T., Calafat, N. J., Gounley, J. P., Ta, A. H., et al. (2019) · Science · doi:10.1126/science.aav9750 · Cited by 1,406 · cited 2× · see citing works
“Recent studies are also focusing on capillary, venous, arterial, and lymphatic vascular networks (Grigoryan et al., 2019).”
BackgroundAdvanced maturation of human cardiac tissue grown from pluripotent stem cells
Ronaldson-Bouchard, K., Ma, S. P., Yeager, K., Chen, T., Song, L., Sirabella, D., Morikawa, K., Teles, D., Yazawa, M., & Vunjak-Novakovic, G. (2018) · Nature · doi:10.1038/s41586-018-0016-3 · Cited by 1,272 · cited 6× · see citing works
“A long-standing limitation of iPSCs, the immaturity of the resulting tissues, is being addressed by inclusion of supporting cells and metabolic and physical regulatory factors (Aleman et al., 2019; Alimperti et al., 2017; Bauer et al., 2017; Benam et al., 2016; Blundell et al., 2016; Keung et al., 2014; Kostrzewski et…”
BackgroundInfluentialSelf-citationPersonalized medicine: Time for one-person trials
Schork, N. J. (2015) · Nature · doi:10.1038/520609a · Cited by 1,235 · cited 2× · see citing works
“Personalized medicine The top 10 clinical drugs in the United States only work in 4%– 25% of patients (Schork, 2015).”
BackgroundPDMS absorption of small molecules and consequences in microfluidic applications
Toepke, M. W., & Beebe, D. J. (2006) · Lab on a Chip · doi:10.1039/b612140c · Cited by 1,193 · cited 1× · see citing works
“As PDMS absorbs hydrophobic compounds, most critically oxygen and many drugs, it hinders control of their concentrations in the cellular environment (Toepke and Beebe, 2006).”
BackgroundOrgans-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185 · cited 1× · see citing works
“Recent years have seen an explosive growth of companies commercializing OOC devices ( 30 companies in 7 years) (Zhang and Radisic, 2017) fueled by their promise to transform drug discovery (Esch et al., 2015).”
BackgroundAdvances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017 · see citing works
Self-citationModelling human development and disease in pluripotent stem-cell-derived gastric organoids
McCracken, K. W., Catá, E. M., Crawford, C. M., Sinagoga, K. L., Schumacher, M., Rockich, B. E., Tsai, Y.-H., Mayhew, C. N., Spence, J. R., Zavros, Y., et al. (2014) · Nature · doi:10.1038/nature13863 · Cited by 980 · cited 1× · see citing works
“The inclusionof apatient’smicrobiome into multi-organ models allows predictive insights into how a patient will respond to a drug therapy (McCracken et al., 2014).”
BackgroundBiowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes
Nunes, S. S., Miklas, J. W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang, J., Massé, S., Gagliardi, M., Hsieh, A., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2524 · Cited by 952 · see citing works
Self-citationKim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522193112 · Cited by 926 · see citing works
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872 · cited 1× · see citing works
“Cancer cell intravasation has been studied using cancer, immune, and vascular multi-organ models, revealing the role of tumor necrosis factor a (TNF-a) in increasing endothelial permeability and cancer cell escape (Zervantonakis et al., 2012).”
BackgroundWang, G., McCain, M. L., Yang, L., He, A., Pasqualini, F. S., Agarwal, A., Yuan, H., Jiang, D., Zhang, D., Zangi, L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3545 · Cited by 837 · see citing works
Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation
Jeon, J. S., Bersini, S., Gilardi, M., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417115112 · Cited by 723 · cited 2× · see citing works
“Breast cancers have similarly been modeled to show propensity for metastasis to bone (Jeon et al., 2015), a result commonly seen clinically but difficult to model in animal systems.”
BackgroundThe n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Lillie, E. O., Patay, B., Diamant, J., Issell, B., Topol, E. J., & Schork, N. J. (2011) · Personalized Medicine · doi:10.2217/pme.11.7 · Cited by 706 · cited 1× · see citing works
“This way, each sample becomes an experiment by itself (‘‘n=1 study’’; Lillie et al., 2011), allowing monitoring of the evolution of biological events, or responses to perturbation.”
MethodBioprinting of 3D convoluted renal proximal tubules on perfusable chips
Homan, K. A., Kolesky, D. B., Skylar-Scott, M. A., Herrmann, J., Obuobi, H., Moisan, A., & Lewis, J. A. (2016) · Scientific Reports · doi:10.1038/srep34845 · Cited by 699 · cited 2× · see citing works
“, 2019), kidney glomerulus and proximal tubule (Zhou et al., 2016; Homan et al., 2016), neuromuscular junction (Afshar Bakooshli et al.”
BackgroundTiburcy, M., Hudson, J. E., Balfanz, P., Schlick, S. F., Meyer, T., Liao, M.-L. C., Levent, E., Raad, F. S., Zeidler, S., Wingender, E., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024145 · Cited by 649 · see citing works
Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy
Hinson, J. T., Chopra, A., Nafissi, N., Polacheck, W. J., Benson, C. C., Swist, S., Gorham, J., Yang, L., Schafer, S., Sheng, C. C., et al. (2015) · Science · doi:10.1126/science.aaa5458 · Cited by 638 · cited 2× · see citing works
“…al., 2010), brain (Harberts et al., 2020) and blood-brain barrier (Vatine et al., 2019), kidney glomerulus and proximal tubule (Zhou et al., 2016; Homan et al., 2016), neuromuscular junction (Afshar Bakooshli et al., 2019), vascular network (Zhang et al., 2016), skin (Abaci et al., 2018), retina…”
BackgroundVatine, G. D., Barrile, R., Workman, M. J., Sances, S., Barriga, B. K., Rahnama, M., Barthakur, S., Kasendra, M., Lucchesi, C., Kerns, J., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.011 · Cited by 632 · see citing works
A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Zhao, Y., Rafatian, N., Feric, N. T., Cox, B. J., Aschar-Sobbi, R., Wang, E. Y., Aggarwal, P., Zhang, B., Conant, G., Ronaldson-Bouchard, K., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.042 · Cited by 610 · cited 6× · see citing works
“A long-standing limitation of iPSCs, the immaturity of the resulting tissues, is being addressed by inclusion of supporting cells and metabolic and physical regulatory factors (Aleman et al., 2019; Alimperti et al., 2017; Bauer et al., 2017; Benam et al., 2016; Blundell et al., 2016; Keung et al., 2014; Kostrzewski et…”
BackgroundMethodInfluentialSelf-citationZhang, B., Montgomery, M., Chamberlain, M. D., Ogawa, S., Korolj, A., Pahnke, A., Wells, L. A., Massé, S., Kim, J., Reis, L., et al. (2016) · Nature Materials · doi:10.1038/nmat4570 · Cited by 593 · cited 2× · see citing works
“The incorporation of nanopores and micro-holes in the vessel walls enhances intercellular crosstalk in vascularized heart and liver OOCs (Zhang et al., 2016).”
BackgroundSelf-citationMusah, S., Mammoto, A., Ferrante, T. C., Jeanty, S. S. F., Hirano-Kobayashi, M., Mammoto, T., Roberts, K., Chung, S., Novak, R., Ingram, M., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0069 · Cited by 550 · cited 2× · see citing works
“A long-standing limitation of iPSCs, the immaturity of the resulting tissues, is being addressed by inclusion of supporting cells and metabolic and physical regulatory factors (Aleman et al., 2019; Alimperti et al., 2017; Bauer et al., 2017; Benam et al., 2016; Blundell et al., 2016; Keung et al., 2014; Kostrzewski et…”
BackgroundHuman iPSC-based Cardiac Microphysiological System For Drug Screening Applications
Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N. C., Mandegar, M. A., Conklin, B. R., Lee, L. P., et al. (2015) · Scientific Reports · doi:10.1038/srep08883 · Cited by 527 · cited 2× · see citing works
“Cells themselves can be tracked in space and time using inducible reporters of cell state or function (Mathur et al., 2015) or on-demand activation (e.”
BackgroundReproducing human and cross-species drug toxicities using a liver-chip
Jang, K.-J., Otieno, M. A., Ronxhi, J., Lim, H.-K., Ewart, L., Kodella, K. R., Petropolis, D. B., Kulkarni, G., Rubins, J. E., Conegliano, D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax5516 · Cited by 511 · cited 1× · see citing works
“This study found liver toxicity and fibrosis from compounds that were discontinued upon rodent studies, proving that OOCs can detect similar effects in rodent-based devices and predict liver injury in humans (Jang et al., 2019).”
BackgroundHerland, A., Maoz, B. M., Das, D., Somayaji, M. R., Prantil‐Baun, R., Novak, R., Cronce, M. J., Huffstater, T. M., Jeanty, S. S. F., Ingram, M., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0498-9 · Cited by 505 · cited 5× · see citing works
“While the need to replace PDMS with inert plastics has been long recognized, some progress has been made only recently by accounting for drug absorption (Herland et al., 2020) or applying inert coatings (Herland et al.”
BackgroundMethodInfluentialInterconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
Edington, C. D., Chen, W. L. K., Geishecker, E., Kassis, T., Soenksen, L. R., Bhushan, B. M., Freake, D., Kirschner, J., Maass, C., Tsamandouras, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22749-0 · Cited by 487 · cited 1× · see citing works
“Advanced circuit designs account for the blood flow each organ receives in vivo (Edington, 2018) Most multi-organ settings include liver, as the primary site of drug metabolism, required for prodrug transformation into its active form.”
BackgroundA microfluidic device for a pharmacokinetic–pharmacodynamic (PK–PD) model on a chip
Sung, J. H., Kam, C., & Shuler, M. L. (2010) · Lab on a Chip · doi:10.1039/b917763a · Cited by 485 · cited 1× · see citing works
“The advantages of microfluidic multi-organ models support their continued development despite additional complexities (Sung et al., 2010).”
BackgroundA microfluidic culture model of the human reproductive tract and 28-day menstrual cycle
Xiao, S., Coppeta, J. R., Rogers, H. B., Isenberg, B. C., Zhu, J., Olalekan, S. A., McKinnon, K. E., Đokić, D., Rashedi, A. S., Haisenleder, D. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14584 · Cited by 485 · cited 2× · see citing works
“The female reproductive system has been modeled in a multiOOC to study hormonal signaling during themenstrual cycle and pregnancy-like endocrine loops by connecting ovary, fallopian tube, uterus, cervix, and liver modules via microfluidic routing (Xiao et al., 2017).”
BackgroundMethodOrgan-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437 · cited 2× · see citing works
“Recent years have seen an explosive growth of companies commercializing OOC devices ( 30 companies in 7 years) (Zhang and Radisic, 2017) fueled by their promise to transform drug discovery (Esch et al.”
BackgroundSelf-citationSung, J. H., & Shuler, M. L. (2009) · Lab on a Chip · doi:10.1039/b901377f · Cited by 431 · cited 1× · see citing works
“An example is the model with microfluidically linked liver, tumor, and marrow established by the OOC pioneer Schuler, using flow rates and residence times matching those in the human body (Sung and Shuler, 2009).”
MethodMaoz, B. M., Herland, A., Fitzgerald, E. A., Grevesse, T., Vidoudez, C., Pacheco, A. R., Sheehy, S. P., Park, T., Dauth, S., Mannix, R. J., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4226 · Cited by 428 · cited 2× · see citing works
“A multi-organ human neurovascular unit developed by coupling blood-brain barrier module (containing human astrocytes and pericytes above a channel lined with brain microvascular endothelial cells) with the brain module (containing primary human brain neurons) recapitulated the blood-brain barrier’s response to methamp…”
BackgroundHuman Engineered Heart Tissue: Analysis of Contractile Force
Mannhardt, I., Breckwoldt, K., Letuffe-Brenière, D., Schaaf, S., Schulz, H., Neuber, C., Benzin, A., Werner, T., Eder, A., Schulze, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.011 · Cited by 398 · cited 1× · see citing works
“Many studies have taken advantage of measuring in real time the contraction frequency and force generation of heart and skeletal muscle from deflection of the anchors at the two ends of the tissue (Mannhardt et al., 2016).”
BackgroundMicromechanical control of cell–cell interactions
Hui, E. E., & Bhatia, S. N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608660104 · Cited by 392 · cited 1× · see citing works
“The importance of heterotypic interactions between hepatocytes and fibroblasts was recognized early on (Hui and Bhatia, 2007), resulting in a commercialized Hepatopac system.”
BackgroundAchberger, K., Probst, C., Haderspeck, J., Bolz, S., Rogal, J., Chuchuy, J., Nikolova, M., Cora, V., Antkowiak, L., Haq, W., et al. (2019) · eLife · doi:10.7554/elife.46188 · Cited by 380 · cited 3× · see citing works
“A mimic of human retina with all seven cell types was created in an OOC with organoids and microvascular channels (Achberger et al., 2019).”
BackgroundMethodSin, A., Chin, K. C., Jamil, M. F., Kostov, Y. V., Rao, G., & Shuler, M. L. (2004) · Biotechnology Progress · doi:10.1021/bp034077d · Cited by 369 · cited 1× · see citing works
“‘‘Organs-on-a-chip’’ (OOC) evolved in the late 1990s, with the idea of ‘‘human-body-on-a-chip’’ for studies of human physiology being introduced shortly thereafter by the Shuler lab (Sin et al., 2004).”
BackgroundEngineering human pluripotent stem cells into a functional skeletal muscle tissue
Rao, L., Qian, Y., Khodabukus, A., Ribar, T. J., & Bursac, N. (2018) · Nature Communications · doi:10.1038/s41467-017-02636-4 · Cited by 340 · cited 1× · see citing works
“, 2019) and derived from human iPSCs (Rao et al., 2018).”
BackgroundScaling and systems biology for integrating multiple organs-on-a-chip
Wikswo, J. P., Curtis, E. L., Eagleton, Z. E., Evans, B. C., Kole, A., Hofmeister, L. H., & Matloff, W. J. (2013) · Lab on a Chip · doi:10.1039/c3lc50243k · Cited by 310 · cited 2× · see citing works
“…models to create multi-organ models The single-organ models can be fluidically connected to create multi-organ models by co-culture in shared media (Wikswo et al., 2013), external media transfer (Vernetti et al., 2017), recirculation using pneumatic pressure-driven actuation (Satoh et al., 2017),…”
BackgroundMethodBenam, K. H., Novak, R., Nawroth, J., Hirano-Kobayashi, M., Ferrante, T. C., Choe, Y., Prantil-Baun, R., Weaver, J. C., Bahinski, A., Parker, K. K., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.10.003 · Cited by 309 · cited 6× · see citing works
“A long-standing limitation of iPSCs, the immaturity of the resulting tissues, is being addressed by inclusion of supporting cells and metabolic and physical regulatory factors (Aleman et al., 2019; Alimperti et al., 2017; Bauer et al., 2017; Benam et al., 2016; Blundell et al., 2016; Keung et al., 2014; Kostrzewski et…”
BackgroundInfluentialTissue engineering of human hair follicles using a biomimetic developmental approach
Abaci, H. E., Coffman, A., Doucet, Y., Chen, J., Jacków, J., Wang, E., Guo, Z., Shin, J. U., Jahoda, C. A., & Christiano, A. M. (2018) · Nature Communications · doi:10.1038/s41467-018-07579-y · Cited by 307 · cited 1× · see citing works
“, 2016), skin (Abaci et al., 2018), retina (Achberger et al.”
Development of a Microscale Cell Culture Analog To Probe Naphthalene Toxicity
Viravaidya‐Pasuwat, K., Sin, A., & Shuler, M. L. (2004) · Biotechnology Progress · doi:10.1021/bp0341996 · Cited by 306 · cited 1× · see citing works
“For example, naphthalene was converted in the liver module into its reactive metabolites and transferred to the lung module, where it depleted cellular glutathione levels and caused the accumulation of hydrophobic compounds in the fat module (Viravaidya et al., 2004).”
BackgroundOn-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology
Chou, D. B., Frismantas, V., Milton, Y., David, R. M., Pop-Damkov, P., Ferguson, D., MacDonald, A., Bölükbaşı, Ö. V., Joyce, C. E., Teixeira, L. M., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0495-z · Cited by 301 · cited 3× · see citing works
“, 2016), bone marrow (Chou et al., 2020) placenta (Blundell et al.”
BackgroundInfluentialMarx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295 · cited 2× · see citing works
“More detail can be found in several excellent reviews (Low et al., 2020; Marx et al., 2016; Takebe et al., 2017).”
BackgroundHuman gut microbiota: the links with dementia development
Alkasir, R., Li, J., Li, X., Jin, M., & Zhu, B. (2016) · Protein & Cell · doi:10.1007/s13238-016-0338-6 · Cited by 283 · see citing works
Vernetti, L. A., Gough, A., Baetz, N. W., Blutt, S. E., Broughman, J. R., Brown, J. A., Foulke-Abel, J. D., Hasan, N. M., In, J., Kelly, E. J., et al. (2017) · Scientific Reports · doi:10.1038/srep42296 · Cited by 274 · cited 1× · see citing works
“, 2013), external media transfer (Vernetti et al., 2017), recirculation using pneumatic pressure-driven actuation (Satoh et al.”
BackgroundAfshar, M., Lippmann, E. S., Mulcahy, B., Iyer, N. R., Nguyen, C. T., Tung, K., Stewart, B. A., van den Dorpel, H., Führmann, T., Shoichet, M. S., et al. (2019) · eLife · doi:10.7554/elife.44530 · Cited by 273 · see citing works
Bauer, S., Wennberg Huldt, C., Kanebratt, K. P., Durieux, I., Gunne, D., Andersson, S., Ewart, L., Haynes, W. G., Maschmeyer, I., Winter, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14815-w · Cited by 272 · cited 3× · see citing works
“…is being addressed by inclusion of supporting cells and metabolic and physical regulatory factors (Aleman et al., 2019; Alimperti et al., 2017; Bauer et al., 2017; Benam et al., 2016; Blundell et al., 2016; Keung et al., 2014; Kostrzewski et al., 2019; Lin et al., 2019; Musah et al., 2017;…”
BackgroundInfluentialXu, Z., Li, E., Guo, Z., Yu, R., Hao, H., Xu, Y., Sun, Z., Li, X., Lyu, J., & Wang, Q. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b08746 · Cited by 264 · cited 4× · see citing works
“Multi-organ models provide tissue-specific insight into cancer cell extravasation (Xu et al., 2016), as lung cancer cells acquire an invasive pheno- 4606 Cell 184, September 2, 2021 type when co-cultured with healthy lung cells, to populate distant bone, brain, and liver organs within the multi-OOC.”
BackgroundInfluentialSynergistic Engineering: Organoids Meet Organs-on-a-Chip
Takebe, T., Zhang, B., & Radisic, M. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.08.016 · Cited by 258 · cited 2× · see citing works
“Clear distinction between OOC and organoids is also important (Takebe et al., 2017) (Figure 1).”
BackgroundSelf-citationA microphysiological model of the human placental barrier
Blundell, C., Tess, E. R., Schanzer, A., Coutifaris, C., Su, E. J., Parry, S. I., & Huh, D. (2016) · Lab on a Chip · doi:10.1039/c6lc00259e · Cited by 253 · cited 4× · see citing works
“…including the use of medium flow to mimic blood perfusion and electrical and mechanical stimuli to drive the maturation of muscle, neural tissues or bone (Alimperti et al., 2017; Blundell et al., 2016; de Graaf et al., 2019; Ronaldson-Bouchard et al., 2018; Vatine et al., 2019; Zhao et al., 2019).”
BackgroundInfluentialRevolutionizing medicine in the 21st century through systems approaches
Hood, L., Balling, R., & Auffray, C. (2012) · Biotechnology Journal · doi:10.1002/biot.201100306 · Cited by 244 · see citing works
Colorectal tumor-on-a-chip system: a 3D tool for precision onco-nanomedicine
Carvalho, M. R., Barata, D., Teixeira, L. M., Giselbrecht, S., Reis, R. L., Oliveira, J. M., Truckenmüller, R., & Habibovic, P. (2019) · Science Advances · doi:10.1126/sciadv.aaw1317 · Cited by 230 · cited 2× · see citing works
“Suchmodels are becoming invaluable for assessing the efficacy of drug-loaded nanoparticles in emerging therapies (Figure 4D) (Carvalho et al., 2019a).”
BackgroundKhodabukus, A., Madden, L. R., Prabhu, N. K., Koves, T. R., Jackman, C. P., Muoio, D. M., & Bursac, N. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.058 · Cited by 227 · cited 1× · see citing works
“Similar to cardiac models, skeletal muscle models can also be matured using electrical stimulation (Khodabukus et al., 2019) and derived from human iPSCs (Rao et al.”
BackgroundGoldfracht, I., Efraim, Y., Shinnawi, R., Kovalev, E., Huber, I., Gepstein, A., Arbel, G., Shaheen, N., Tiburcy, M., Zimmermann, W. H., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.016 · Cited by 222 · cited 1× · see citing works
“Likewise, calcium flux measurements are already well established for a number of tissue systems (Goldfracht et al., 2019).”
BackgroundKirkton, R. D., Santiago-Maysonet, M., Lawson, J. H., Tente, W. E., Dahl, S. L. M., Niklason, L. E., & Prichard, H. L. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6934 · Cited by 210 · cited 1× · see citing works
“Tissue-engineered blood vessels will hopefully follow soon, as the clinical trials in atrioventricular shunt patients are being completed (Kirkton et al., 2019).”
BackgroundGrassart, A., Malardé, V., Gobaa, S., Sartori-Rupp, A., Kerns, J., Karalis, K., Marteyn, B., Sansonetti, P., & Sauvonnet, N. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.08.007 · Cited by 206 · see citing works
Trapecar, M., Communal, C., Velazquez, J., Maass, C. A., Huang, Y.-J., Schneider, K., Wright, C. W., Butty, V., Eng, G., Yilmaz, O., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.02.008 · Cited by 204 · see citing works
Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics
McAleer, C. W., Long, C. J., Elbrecht, D., Sasserath, T., Bridges, L. R., Rumsey, J. W., Martin, C., Schnepper, M., Wang, Y., Schuler, F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav1386 · Cited by 199 · cited 1× · see citing works
“Models of human safety and efficacy (phase 2/3) Multi-OOCs have been able to accurately model both the ontarget effects of cancer therapies and off-target heart and liver toxicity for drugs involving liver metabolism (McAleer et al., 2019).”
BackgroundVernetti, L. A., Gough, A., Baetz, N. W., Blutt, S. E., Broughman, J. R., Brown, J. A., Foulke-Abel, J. D., Hasan, N. M., In, J., Kelly, E. J., et al. (2017) · Scientific Reports · doi:10.1038/srep44517 · Cited by 189 · see citing works
Qiu, Y., Ahn, B., Sakurai, Y., Hansen, C. E., Tran, R., Mimche, P. N., Mannino, R. G., Ciciliano, J. C., Lamb, T. J., Joiner, C. H., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0224-z · Cited by 188 · cited 1× · see citing works
“recapitulating the blood vessel intima, to study the inflammatory mediators of barrier function and sickle cell occlusion (Qiu et al., 2018) (Figure 4C).”
BackgroundSatoh, T., Sugiura, S., Shin, K., Onuki-Nagasaki, R., Ishida, S., Kikuchi, K., Kakiki, M., & Kanamori, T. (2018) · Lab on a Chip · doi:10.1039/c7lc00952f · Cited by 181 · cited 1× · see citing works
“, 2017), recirculation using pneumatic pressure-driven actuation (Satoh et al., 2017), and peristaltic pumps (Chramiec et al.”
BackgroundEngineering a perfusable 3D human liver platform from iPS cells
Schepers, A. G., Li, C. Y., Chhabra, A., Tschudy-Seney, B., & Bhatia, S. N. (2016) · Lab on a Chip · doi:10.1039/c6lc00598e · Cited by 174 · cited 2× · see citing works
“, 2019; Tiburcy, 2017), liver ((Kostrzewski et al., 2019; Schepers et al., 2016) alveolar unit of the lung (Huh et al.”
BackgroundIFlowPlate—A Customized 384‐Well Plate for the Culture of Perfusable Vascularized Colon Organoids
Rajasekar, S., Lin, D. S. Y., Abdul, L., Liu, A. W. K., Sotra, A., Zhang, F., & Zhang, B. (2020) · Advanced Materials · doi:10.1002/adma.202002974 · Cited by 167 · cited 1× · see citing works
“Up to 128 independent vascularized colons-on-a-chip were formed in a 384-well-plate platform with gravity flow that supported modeling of colon inflammation with innate immune function (Rajasekar et al., 2020).”
Zhou, M., Zhang, X., Wen, X., Wu, T., Wang, W., Yang, M., Wang, J., Fang, M., Lin, B., & Lin, H. (2016) · Scientific Reports · doi:10.1038/srep31771 · Cited by 162 · cited 2× · see citing works
“, 2019), kidney glomerulus and proximal tubule (Zhou et al., 2016; Homan et al., 2016), neuromuscular junction (Afshar Bakooshli et al.”
BackgroundMultiscale reverse engineering of the human ocular surface
Seo, J., Byun, W. Y., Alisafaei, F., Georgescu, A., Yi, Y., Massaro‐Giordano, M., Shenoy, V. B., Lee, V., Bunya, V. Y., & Huh, D. (2019) · Nature Medicine · doi:10.1038/s41591-019-0531-2 · Cited by 149 · cited 1× · see citing works
“The patterned cells are periodically lubricated by a hydrogel lid to create a blinking-eye-on-a-chip (Seo et al., 2019).”
BackgroundEngineering of human cardiac muscle electromechanically matured to an adult-like phenotype
Ronaldson-Bouchard, K., Yeager, K., Teles, D., Chen, T., Ma, S., Song, L., Morikawa, K., Wobma, H. M., Vasciaveo, A., Ruiz, E. C., et al. (2019) · Nature Protocols · doi:10.1038/s41596-019-0189-8 · Cited by 144 · cited 2× · see citing works
“An example is the engineered heart muscle matured by electromechanical conditioning with the force generation and conduction developing more slowly and to a lesser extent than structural features (Ronaldson-Bouchard et al., 2018; Ronaldson-Bouchard et al., 2019).”
BackgroundSelf-citationLai, B. F. L., Lu, R. X. Z., Hu, Y., Davenport Huyer, L., Dou, W., Wang, E. Y., Radulovich, N., Tsao, M. S., Sun, Y., & Radisic, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000545 · Cited by 142 · cited 4× · see citing works
“…OOC devices are on the order of micrometers to millimeters in size, whereas regenerative engineering re-creates structures on the order of millimeters to centimeters. ll Review 2016), and tumors (Lai et al., 2020), all of which are being used to study tissue maturation, regeneration, and disease.”
BackgroundMethodInfluentialSelf-citationLi, X., George, S. M., Vernetti, L. A., Gough, A., & Taylor, D. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00418h · Cited by 138 · cited 1× · see citing works
“Recent PDMS-free OOCs with separate hepatic and vascular channels (incorporating primary human hepatocytes and sinusoidal endothelial cells and stellate and Kupffer cell lines) recapitulated the liver acinus and oxygen zonation (Li et al., 2018).”
BackgroundMicrofluidic vascularized bone tissue model with hydroxyapatite-incorporated extracellular matrix
Jusoh, N., Oh, S., Kim, S., Jangho, K., & Jeon, N. L. (2015) · Lab on a Chip · doi:10.1039/c5lc00698h · Cited by 136 · cited 2× · see citing works
“An OOC model of vascularized bone was also created by inducing microvascular flow into the mineralized ECM populated by bone-forming cells (Jusoh et al., 2015).”
BackgroundPiccini, J. P., Whellan, D. J., Berridge, B. R., Finkle, J. K., Pettit, S. D., Stockbridge, N., Valentin, J., Vargas, H. M., & Krucoff, M. W. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.007 · Cited by 125 · see citing works
Alimperti, S., Mirabella, T., Bajaj, V., Polacheck, W., Pirone, D. M., Duffield, J., Eyckmans, J., Assoian, R. K., & Chen, C. S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618333114 · Cited by 122 · cited 3× · see citing works
“A long-standing limitation of iPSCs, the immaturity of the resulting tissues, is being addressed by inclusion of supporting cells and metabolic and physical regulatory factors (Aleman et al., 2019; Alimperti et al., 2017; Bauer et al., 2017; Benam et al., 2016; Blundell et al., 2016; Keung et al., 2014; Kostrzewski et…”
BackgroundOsteochondral Tissue Chip Derived From iPSCs: Modeling OA Pathologies and Testing Drugs
Lin, Z., Li, Z. A., Li, E. N., Li, X., Duke, C. D., Shen, H., Hao, T., O’Donnell, B. T., Bunnell, B. A., Goodman, S. B., et al. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00411 · Cited by 122 · see citing works
Toepfer, C. N., Sharma, A., Cicconet, M., Garfinkel, A. C., Mücke, M. B., Neyazi, M., Willcox, J. A. L., Agarwal, R., Schmid, M., Rao, J., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314505 · Cited by 119 · see citing works
Chramiec, A. G., Teles, D., Yeager, K. J., Marturano-Kruik, A., Pak, J., Chen, T. F., Hao, L. Y., Wang, M. C., Lock, R. I., Tavakol, D. N., et al. (2020) · Lab on a Chip · doi:10.1039/d0lc00424c · Cited by 119 · cited 3× · see citing works
“Multi-organ model screening of the anti-cancer drug linsitinib recapitulated clinical findings, including limited efficacy of the drug in treating bone tumors and limited cardiac toxicity in the human setting (Chramiec et al., 2020).”
BackgroundSelf-citationTopol, E. J. (2020) · Science · doi:10.1126/science.abe2813 · Cited by 117 · cited 2× · see citing works
“, 2016), and precision medicine app side effects in asymptomatic and recovering coronavirus disease 2019 (COVID-19)-infected individuals (Topol, 2020).”
BackgroundResultHuman Organs-on-Chips for Virology
Tang, H., Abouleila, Y., Si, L., Ortega‐Prieto, A. M., Mummery, C. L., Ingber, D. E., & Mashaghi, A. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.06.005 · Cited by 114 · cited 1× · see citing works
“OOCs have been invaluable for the studies of SARS-CoV-2 and other viral infections associated with organ dysfunction (Tang et al., 2020).”
BackgroundAfshar, M. E., Abraha, H. Y., Bakooshli, M. A., Davoudi, S., Thavandiran, N., Tung, K., Ahn, H., Ginsberg, H. J., Zandstra, P. W., & Gilbert, P. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-62837-8 · Cited by 113 · see citing works
Marchianò, S., Hsiang, T.-Y., Khanna, A., Higashi, T., Whitmore, L. S., Bargehr, J., Davaapil, H., Chang, J., Smith, E. A., Ong, L. P., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.008 · Cited by 110 · cited 1× · see citing works
“The heart OOC demonstrated profound contractile dysfunction (Marchiano et al., 2020), consistent with the recent reports of cardiac”
ResultThe intercell dynamics of T cells and dendritic cells in a lymph node-on-a-chip flow device
Rosa, P. M., Gopalakrishnan, N. V., Ibrahim, H., Haug, M., & Halaas, Ø. (2016) · Lab on a Chip · doi:10.1039/c6lc00702c · Cited by 107 · cited 1× · see citing works
“Lymph-node-on-a-chip was modeled using a PDMS channel with two inlets and two outlets, supporting a monolayer of dendritic cells to which T cells can be bound during flow in an antigen-specific manner (Moura Rosa et al., 2016).”
MethodMejías, J. C., Nelson, M. R., Liseth, O. Y., & Roy, K. (2020) · Lab on a Chip · doi:10.1039/d0lc00644k · Cited by 103 · cited 1× · see citing works
“A multi-layered lungon-a-chip with patterned vasculature and lung channels was used to form cystic-fibrosis-like epithelium and study neutrophil migration (Mejı́as et al., 2020).”
MethodInVADE: integrated vasculature for assessing dynamic events
Lai, B. F. L., Huyer, L. D., Lu, R. X. Z., Drecun, S., Radisic, M., & Zhang, B. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703524 · Cited by 97 · cited 1× · see citing works
“This platform can be scaled down to a footprint of a 96-well plate (Figure 4G) using the InVADE system, requiring only 100,000 cells per tissue and enabling facile connections of tumor and liver tissues (Lai et al., 2017; Lai et al., 2020).”
MethodSelf-citationEngineering a 3D functional human peripheral nerve in vitro using the Nerve-on-a-Chip platform
Sharma, A. D., McCoy, L., Jacobs, E. H., Willey, H., Behn, J. Q., Nguyen, H. T., Bolon, B. N., Curley, J. L., & Moore, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-45407-5 · Cited by 96 · cited 3× · see citing works
“Reproduced with permission from (Sharma et al., 2019a).”
BackgroundInfluentialde Mello, C. P. P., Carmona‐Moran, C. A., McAleer, C. W., Perez, J., Coln, E. A., Long, C. J., Oleaga, C., Riu, A., Note, R., Teissier, S., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc00861f · Cited by 94 · see citing works
h-FIBER: Microfluidic Topographical Hollow Fiber for Studies of Glomerular Filtration Barrier
Xie, R., Korolj, A., Liu, C., Song, X., Lu, R. X. Z., Zhang, B., Ramachandran, A., Liang, Q., & Radisic, M. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01097 · Cited by 93 · cited 1× · see citing works
“, 2016), microfluidic spinning of glomerulus-on-a-chip (Xie et al., 2020), and stereolithographic printing of microvasculature and lung alveoli in photopolymerizable hydrogels using food colors as photoabsorbers (Grigoryan et al.”
BackgroundSelf-citationDifferential Monocyte Actuation in a Three‐Organ Functional Innate Immune System‐on‐a‐Chip
Sasserath, T., Rumsey, J. W., McAleer, C. W., Bridges, L. R., Long, C. J., Elbrecht, D. H., Schuler, F., Roth, A. B., Bertinetti‐LaPatki, C., Shuler, M. L., et al. (2020) · Advanced Science · doi:10.1002/advs.202000323 · Cited by 93 · see citing works
Habert, R., Muczynski, V., Grisin, T., Moison, D., Messiaen, S., Frydman, R., Benachi, A., Delbès, G., Lambrot, R., Lehraiki, A., et al. (2014) · Reproduction · doi:10.1530/rep-13-0497 · Cited by 88 · cited 1× · see citing works
“The immune and endocrine systems are particularly important, as they interact with all organ systems in the body and are poorly modeled in animals (Habert et al., 2014).”
BackgroundModeling alcohol-associated liver disease in a human Liver-Chip
Nawroth, J. C., Petropolis, D. B., Manatakis, D. V., Maulana, T. I., Burchett, G., Schlünder, K., Witt, A., Shukla, A., Kodella, K., Ronxhi, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109393 · Cited by 88 · see citing works
Keung, W., Boheler, K. R., & Li, R. A. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt406 · Cited by 87 · cited 2× · see citing works
“A long-standing limitation of iPSCs, the immaturity of the resulting tissues, is being addressed by inclusion of supporting cells and metabolic and physical regulatory factors (Aleman et al., 2019; Alimperti et al., 2017; Bauer et al., 2017; Benam et al., 2016; Blundell et al., 2016; Keung et al., 2014; Kostrzewski et…”
BackgroundAleman, J., George, S. K., Herberg, S., Devarasetty, M., Porada, C. D., Skardal, A., & Almeida-Porada, G. D. (2019) · Small · doi:10.1002/smll.201902971 · Cited by 86 · cited 3× · see citing works
“A long-standing limitation of iPSCs, the immaturity of the resulting tissues, is being addressed by inclusion of supporting cells and metabolic and physical regulatory factors (Aleman et al., 2019; Alimperti et al., 2017; Bauer et al., 2017; Benam et al., 2016; Blundell et al., 2016; Keung et al., 2014; Kostrzewski et…”
BackgroundRothbauer, M., Höll, G., Eilenberger, C., Kratz, S. R. A., Farooq, B., Schuller, P., Calvo, I. O., Byrne, R. A., Meyer, B., Niederreiter, B., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc01097a · Cited by 85 · cited 1× · see citing works
“Patient-derived primary synovial organoids were cultivated in the absence and presence of tumor necrosis factor by noninvasive detection of changes in tissue architecture via light scattering (Rothbauer et al., 2020).”
BackgroundNorona, L. M., Nguyen, D. G., Gerber, D. A., Presnell, S. C., Mosedale, M., & Watkins, P. B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0208958 · Cited by 79 · cited 1× · see citing works
“Sensing of drug injury was demonstrated through incorporation of Kupffer cells into Organovo’s 3D-printed liver spheroids (Norona et al., 2019).”
Background3D curvature-instructed endothelial flow response and tissue vascularization
Mandrycky, C., Hadland, B., & Zheng, Y. Y. (2020) · Science Advances · doi:10.1126/sciadv.abb3629 · Cited by 79 · cited 1× · see citing works
“vasculature in collagen hydrogel (Mandrycky et al., 2020), an important consideration for epithelial/endothelial barriers.”
BackgroundA Microphysiological System for Studying Nonalcoholic Steatohepatitis
Kostrzewski, T., Maraver, P., Ouro‐Gnao, L., Levi, A., Snow, S., Miedzik, A., Rombouts, K., & Hughes, D. (2020) · Hepatology Communications · doi:10.1002/hep4.1450 · Cited by 77 · cited 2× · see citing works
“A long-standing limitation of iPSCs, the immaturity of the resulting tissues, is being addressed by inclusion of supporting cells and metabolic and physical regulatory factors (Aleman et al., 2019; Alimperti et al., 2017; Bauer et al., 2017; Benam et al., 2016; Blundell et al., 2016; Keung et al., 2014; Kostrzewski et…”
BackgroundScalable microphysiological system to model three-dimensional blood vessels
de Graaf, M. N. S., Cochrane, A., van den Hil, F. E., Buijsman, W., van der Meer, A. D., van den Berg, A., Mummery, C. L., & Orlova, V. V. (2019) · APL Bioengineering · doi:10.1063/1.5090986 · Cited by 71 · see citing works
Harberts, J. I., Fendler, C., Teuber, J., Siegmund, M., Trenkle, A. D. S., Rieck, N., Wolpert, M., Zierold, R., & Blick, R. H. (2020) · ACS Nano · doi:10.1021/acsnano.0c04640 · Cited by 68 · cited 2× · see citing works
“…Zhao et al., 2019; Tiburcy, 2017), liver ((Kostrzewski et al., 2019; Schepers et al., 2016) alveolar unit of the lung (Huh et al., 2010), brain (Harberts et al., 2020) and blood-brain barrier (Vatine et al., 2019), kidney glomerulus and proximal tubule (Zhou et al., 2016; Homan et al., 2016),…”
BackgroundQuantification of human neuromuscular function through optogenetics
Vila, O. F., Uzel, S. G. M., Ma, S. P., Williams, D. J., Pak, J., Kamm, R. D., & Vunjak‐Novakovic, G. (2019) · Theranostics · doi:10.7150/thno.25735 · Cited by 62 · cited 1× · see citing works
“In another study, the first patient-specific model of NMJ was established using muscle cells and optogenetically edited motoneurons to model myasthenia gravis, an autoimmune disease resulting in NMJ dysfunction (Vila et al., 2019).”
BackgroundSelf-citationTissue engineered autologous cartilage-bone grafts for temporomandibular joint regeneration
Chen, D., Wu, J. Y., Kennedy, K. M., Yeager, K. J., Bernhard, J., Ng, J., Zimmerman, B., Robinson, S. T., Durney, K. M., Shaeffer, C., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb6683 · Cited by 58 · see citing works
Self-citationVirumbrales-Muñoz, M., Chen, J., Ayuso, J., Lee, M., Abel, E. J., & Beebe, D. J. (2020) · Lab on a Chip · doi:10.1039/d0lc00252f · Cited by 39 · cited 1× · see citing works
“RNAsequencingofbloodvessels allowed selection of candidate drugs, ultimately leading to the testing of sirolimus and nintedanib (Virumbrales-Munoz et al., 2020).”
BackgroundLow, L. A., Sutherland, M. L., Lumelsky, N. L., Selimović, Š., Lundberg, M. S., & Tagle, D. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36588-2_3 · Cited by 33 · cited 1× · see citing works
“More detail can be found in several excellent reviews (Low et al., 2020; Marx et al., 2016; Takebe et al., 2017).”
BackgroundHayward, K. L., Kouthouridis, S., & Zhang, B. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01089 · Cited by 31 · cited 1× · see citing works
“As fibrosis affects essentially all organs as the end stage of various diseases and injuries, recent OOC studies have focused on recapitulating fibrosis (Hayward et al., 2021).”
BackgroundMarchianò, S., Hsiang, T.-Y., Higashi, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.30.274464 · Cited by 19 · see citing works
Modeling Alcoholic Liver Disease in a Human Liver-ChipPreprint
Nawroth, J. C., Petrópolis, D. B., Manatakis, D. V., Maulana, T. I., Burchett, G., Schlünder, K., Witt, A., Shukla, A., Hamilton, G. A., Seki, E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.14.203166 · Cited by 6 · see citing works
Oyirifi, A., Joyce, K. M., Helferich, W. G., & Imoukhuede, P. I. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.647.30 · Cited by 2 · cited 2× · see citing works
“By coupling multiple OOCs together through vascular perfusion of a shared blood substitute or supernatant exchange, one can study organ-organ interactions and systemic diseases such as cancer (Jeon et al., 2015; Oyirifi et al., 2019; Xu et al., 2016), inflammation (Lin et al.”
Background
Flagged first, then by citations
5 of the 110 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [76]Si L, Bai H, Rodas M, Cao W, Oh CY, Jiang A, Nurani A, Zhu DY, Goyal G, Gilpin SE, (2020). Human organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemics. bioRxiv, 2020.2004.2013.039917.
Cited by
Sorted by citations
A guide to the organ-on-a-chip
Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116 · see citing works
Self-citationThe role of goblet cells and mucus in intestinal homeostasis
Gustafsson, J. K., & Johansson, M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00675-x · Cited by 698 · see citing works
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452 · see citing works
“187 188 – 194 OoCs have separate compartments and are constantly perfused, enabling controlled tissue assembly, exposure to shear fl uid forces, and separation of culture medium reservoirs.”
BackgroundHepatic fibrosis 2022: Unmet needs and a blueprint for the future
Friedman, S. L., & Pinzani, M. (2022) · Hepatology · doi:10.1002/hep.32285 · Cited by 430 · see citing works
Phenotypic drug discovery: recent successes, lessons learned and new directions
Vincent, F., Nueda, A., Lee, J. L. C., Schenone, M., Prunotto, M., & Mercola, M. A. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00472-w · Cited by 372 · see citing works
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331 · see citing works
Organ-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z. H., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 272 · see citing works
“OoCs are now starting to attract AI, especially the machine learning (ML) and deep learning (DL) approaches to experimental design and data interpretation [57].”
BackgroundIntegrating organoids and organ-on-a-chip devices
Zhao, Y., Landau, S., Okhovatian, S., Liu, C., Lu, R. X. Z., Lai, B. F. L., Wu, Q., Kieda, J., Cheung, K., Rajasekar, S., et al. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00207-z · Cited by 206 · see citing works
“Other biofabrication approaches have demonstrated vascular lumens with cell infiltration 173,174,178 , including those from commercial sources, such as Nortis, Emulate, Aracari, AIM Biotech or Mimetas 8,180 .”
InfluentialSelf-citationChallenges and opportunities for the next generation of cardiovascular tissue engineering
Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G., & Wu, J. C. (2022) · Nature Methods · doi:10.1038/s41592-022-01591-3 · Cited by 176 · see citing works
Self-citationPolymer-based responsive structural color materials
Wang, H., Zhang, H., Chen, Z., Zhao, Y., Gu, Z., & Shang, L. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101091 · Cited by 139 · see citing works
The Discovery of Extracellular Vesicles and Their Emergence as a Next-Generation Therapy
Rai, A., Claridge, B., Lozano, J., & Greening, D. W. (2024) · Circulation Research · doi:10.1161/circresaha.123.323054 · Cited by 135 · see citing works
The neurovascular unit and systemic biology in stroke — implications for translation and treatment
Tiedt, S., Buchan, A. M., Dichgans, M., Lizasoaín, I., Moro, M. Á., & Lo, E. H. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00703-z · Cited by 132 · see citing works
Shiwarski, D. J., Hudson, A. R., Tashman, J. W., Bakırcı, E., Moss, S., Coffin, B. D., & Feinberg, A. W. (2025) · Science Advances · doi:10.1126/sciadv.adu5905 · Cited by 120 · see citing works
“These microphysiological systems have proved to be useful platforms for studying vasculogenesis and angiogenesis, as well as modeling human diseases and pharmaceutical responses that cannot be studied in patients ( 7 ).”
Microfluidic high-throughput 3D cell culture
Ko, J., Park, D., Lee, J., Jung, S., Baek, K., Sung, K. E., Lee, J., & Jeon, N. L. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00163-8 · Cited by 88 · see citing works
Zhu, J., Ji, L., Chen, Y., Li, H., Huang, M., Dai, Z., Wang, J., Xiang, D., Fu, G., Lei, Z., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01354-9 · Cited by 87 · see citing works
“The dynamic study of microenvironment, the reduction of using animal models, novel drug development, drug efficacy, and toxicity assessment are all areas of applied research in organ chips technology that are currently in full swing [63].”
BackgroundStem cell-derived intestinal organoids: a novel modality for IBD
Tian, C., Yang, M., Xu, H., Zhu, M., Yue, N.-N., Zhang, Y., Shi, R., Yao, J., Wang, L., Liang, Y.-J., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01556-1 · Cited by 85 · see citing works
Synovial joint-on-a-chip for modeling arthritis: progress, pitfalls, and potential
Li, Z. A., Sant, S., Cho, S. K., Goodman, S. B., Bunnell, B. A., Tuan, R. S., Gold, M. S., & Lin, H. (2022) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.07.011 · Cited by 78 · see citing works
Maurissen, T. L., Spielmann, A. J., Schellenberg, G., Bickle, M., Vieira, J. R., Lai, S. Y., Pavlou, G., Fauser, S., Westenskow, P. D., Kamm, R. D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45456-z · Cited by 73 · see citing works
“Bioengineered human model systems closely mimic the physiological organization and function of native tissues, enabling researchers to investigate disease mechanisms and response to treatments 3 .”
Microfluidics meets 3D cancer cell migration
Mehta, P., Rahman, Z., ten Dijke, P., & Boukany, P. E. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.03.006 · Cited by 72 · see citing works
Electroconductive and Anisotropic Structural Color Hydrogels for Visual Heart‐on‐a‐Chip Construction
Sun, L., Chen, Z., Xu, D., & Zhao, Y. (2022) · Advanced Science · doi:10.1002/advs.202105777 · Cited by 68 · see citing works
Advances in organ-on-a-chip systems for modelling joint tissue and osteoarthritic diseases
Banh, L., Cheung, K. K., Chan, M. W. Y., Young, E. W. K., & Viswanathan, S. (2022) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2022.03.012 · Cited by 69 · see citing works
Patient‐derived cancer organoids for drug screening: Basic technology and clinical application
Ren, X., Chen, W., Yang, Q., Li, X., & Xu, L. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15930 · Cited by 69 · see citing works
Roadblocks confronting widespread dissemination and deployment of Organs on Chips
Alver, C. G., Drabbe, E., Ishahak, M., & Agarwal, A. (2024) · Nature Communications · doi:10.1038/s41467-024-48864-3 · Cited by 74 · see citing works
“While traditional 2D culture methods have served the scienti fi c community well over the past century, the development of Organ on Chip devices has improved the ability to culture more complex 3D engineered and ex-vivo tissues 1 – 6 .”
Approaching Two Decades: Biomolecular Coronas and Bio–Nano Interactions
Li, S., Cortez‐Jugo, C., Ju, Y., & Caruso, F. (2024) · ACS Nano · doi:10.1021/acsnano.4c13214 · Cited by 64 · see citing works
Standardizing designed and emergent quantitative features in microphysiological systems
Nahon, D. M., Moerkens, R., Aydoğmuş, H., Lendemeijer, B., Martínez-Silgado, A., Stein, J. M., Dostanić, M., Frimat, J., Gontan, C., de Graaf, M. N. S., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01236-0 · Cited by 62 · see citing works
“The first examples of how these advanced model systems can impact toxicological, pharmaceutical and biomedical science are beginning to emerge 1,2 .”
Modeling Heart Diseases on a Chip: Advantages and Future Opportunities
Mourad, O., Yee, R., Li, M., & Nunes, S. S. (2023) · Circulation Research · doi:10.1161/circresaha.122.321670 · Cited by 60 · see citing works
Glioblastoma-on-a-chip construction and therapeutic applications
Xie, Z., Chen, M., Lian, J., Wang, H., & Ma, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1183059 · Cited by 59 · see citing works
The tendon microenvironment: Engineered in vitro models to study cellular crosstalk
Gómez‐Florit, M., Labrador‐Rached, C. J., Domingues, R. M. A., & Gomes, M. E. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114299 · Cited by 52 · see citing works
Cognetti, J. S., Moen, M. T., Brewer, M. G., Bryan, M. R., Tice, J. D., McGrath, J. L., & Miller, B. L. (2022) · Lab on a Chip · doi:10.1039/d2lc00864e · Cited by 52 · see citing works
From organoids to organoids-on-a-chip: Current applications and challenges in biomedical research
Liu, K., Chen, X., Fan, Z., Ren, F., Liu, J., & Hu, B. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003535 · Cited by 56 · see citing works
“[3,54] [71,135,136] Modeling development of specific brain regions, cortical layering, early neurogenesis, synapse formation, and spontaneous electrical activity Size limit due to oxygen and nutrient diffusion constraints; lack of microvascular differentiation; absence of microglial cells; can not…”
Magnetically driven formation of 3D freestanding soft bioscaffolds
Xie, R., Cao, Y., Sun, R., Wang, R., Morgan, A., Kim, J., Callens, S. J. P., Xie, K., Zou, J., Lin, J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl1549 · Cited by 46 · see citing works
Recent Advances in Generation of In Vitro Cardiac Organoids
Sahara, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076244 · Cited by 47 · see citing works
“In regards to topics of other in vitro 3D culture models, including various EHT models [16,26], a microfluidics/heart-on-a-chip [27,28], bioprinting [29,30], and electrospinning [31,32], the author asks readers to refer to the suggested reviews, respectively.”
BackgroundGorodetska, I., Offermann, A., Püschel, J., Lukiyanchuk, V., Gaete, D., Kurzyukova, A., Freytag, V., Haider, M., Fjeldbo, C. S., Gaetano, S. D., et al. (2024) · Theranostics · doi:10.7150/thno.88057 · Cited by 46 · see citing works
“Employing patient-derived ex vivo models such as organs-on-a-chip providing physiologically relevant microenvironment [92] could be an alternative approach to further validate these findings.”
ResultHarnessing the power of artificial intelligence for human living organoid research
Wang, H., Li, X., You, X., & Zhao, G. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.08.027 · Cited by 43 · see citing works
“It can in vitro partially replicate organ-specific structures (e.g., villi, gas-liquid interface, blood vessel, and neural networks, etc) and realize key functions (e. g., blood-brain barrier, rhythmic respiration, peristalsis, and angiogenesis, etc) [72 – 74].”
BackgroundEngineering complexity in human tissue models of cancer
Ronaldson-Bouchard, K., Baldassarri, I., Tavakol, D. N., Graney, P. L., Samaritano, M., Cimetta, E., & Vunjak‐Novakovic, G. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114181 · Cited by 41 · see citing works
“and OOC models is to provide biological complexity while keeping the models user-friendly [59,75].”
BackgroundSelf-citationStrengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes
Raniga, K., Nasir, A., Vo, N. T. N., Vaidyanathan, R., Dickerson, S., Hilcove, S. A., Mosqueira, D., Mirams, G. R., Clements, P., Hicks, R., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.01.007 · Cited by 38 · see citing works
What Can an Organ-on-a-Chip Teach Us About Human Lung Pathophysiology?
Bai, H., & Ingber, D. E. (2022) · Physiology · doi:10.1152/physiol.00012.2022 · Cited by 39 · see citing works
Analysis of drug efficacy for inflammatory skin on an organ-chip system
Quan, Q., Weng, D., Li, X., An, Q., Yang, Y., Yu, B., Ma, Y., & Wang, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.939629 · Cited by 37 · see citing works
“In recent years, with the help of organ-on-chip technologies, researchers can design amicroenvironment close to physiological conditions to obtain more complete organ structure and mature tissue function in vitro (Trietsch et al., 2017; Vunjak-Novakovic et al., 2021).”
BackgroundHumayun, M., Ayuso, J. M., Park, K. Y., Genova, B. M. D., Skala, M. C., Kerr, S. C., Knoll, L. J., & Beebe, D. J. (2022) · Science Advances · doi:10.1126/sciadv.abm8012 · Cited by 34 · see citing works
Perspectives on organ-on-a-chip technology for natural products evaluation
Wang, X., Miao, Y., Zhao, X.-M., Liu, X., Hu, Y.-W., & Deng, D. (2024) · Food & medicine homology. · doi:10.26599/fmh.2024.9420013 · Cited by 36 · see citing works
Generative AI: driving productivity and scientific breakthroughs in pharmaceutical R&D
Doron, G., Genway, S., Roberts, M., & Jasti, S. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104272 · Cited by 36 · see citing works
Tang, Y., Tian, F., Miao, X., Wu, D., Wang, Y., Wang, H., You, K., Li, Q., Zhao, S., & Wang, W. (2022) · Biofabrication · doi:10.1088/1758-5090/ac975d · Cited by 35 · see citing works
“Recent advancements in the development of stem-cell technology, especially the flourishing human-induced pluripotent stem cell (hiPSC), enable us to overcome species differences and allow human cardiomyocytes (CMs) to be abundantly available via the differentiation of hiPSCs for the construction of in vitro human card…”
Advancing Intelligent Organ‐on‐a‐Chip Systems with Comprehensive In Situ Bioanalysis
Li, X., Zhu, H. J., Gu, B., Yao, C., Gu, Y., Xu, W., Zhang, J., He, J., Liu, X., & Li, D. (2023) · Advanced Materials · doi:10.1002/adma.202305268 · Cited by 37 · see citing works
Emerging microfluidics-enabled platforms for osteoarthritis management: from benchtop to bedside
Zou, Z., Luo, X., Chen, Z., Zhang, Y. S., & Wen, C. (2021) · Theranostics · doi:10.7150/thno.62685 · Cited by 33 · see citing works
“An OOC device is a microfluidics-based 3D cell culture platform that mimics the essential functional aspects of specific organs or tissues [40-44].”
BackgroundEngineering Cardiac Tissue for Advanced Heart‐On‐A‐Chip Platforms
Chen, X., Liu, S., Han, M., Long, M., Li, T., Hu, L., Wang, L., Huang, W., & Wu, Y. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301338 · Cited by 35 · see citing works
In situ biosensing technologies for an organ-on-a-chip
Kim, J., Kim, J., Jin, Y., & Cho, S. (2023) · Biofabrication · doi:10.1088/1758-5090/aceaae · Cited by 34 · see citing works
“Multi-organs-on-chips allow the monitoring of the potential interaction between organs, as well as the systemic modeling of diseases, by availing cross-organ communication [7, 26, 27].”
Rapid Prototyping of Organ-on-a-Chip Devices Using Maskless Photolithography
Kasi, D. G., de Graaf, M. N. S., Motreuil-Ragot, P., Frimat, J., Ferrari, M. D., Sarro, P. M., Mastrangeli, M., van den Maagdenberg, A. M. J. M., Mummery, C. L., & Orlova, V. V. (2021) · Micromachines · doi:10.3390/mi13010049 · Cited by 32 · see citing works
Progress in Bioengineering Strategies for Heart Regenerative Medicine
Häneke, T., & Sahara, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073482 · Cited by 32 · see citing works
McCloskey, M. C., Kasap, P., Ahmad, S. D., Su, S., Chen, K., Mansouri, M., Ramesh, N., Nishihara, H., Belyaev, Y., Abhyankar, V. V., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202200804 · Cited by 35 · see citing works
Modeling the Effects of Protracted Cosmic Radiation in a Human Organ‐on‐Chip Platform
Tavakol, D. N., Nash, T. R., Kim, Y., Graney, P. L., Liberman, M., Fleischer, S., Lock, R. I., O'Donnell, A., Andrews, L., Ning, D., et al. (2024) · Advanced Science · doi:10.1002/advs.202401415 · Cited by 30 · see citing works
Self-citationMartinez, M. G. V., Frauenlob, M., & Rothbauer, M. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2362183 · Cited by 31 · see citing works
“Notably, as a variety of reviews have already focused on general developments of the last decade in the field [35–39] we only included reports from the last three years of biochip advances that in our opinion noteworthy instances due to their chip manufacturing and perfusion approaches, in order to…”
BackgroundFabrication of organ-on-a-chip using microfluidics
Ying-Jin, S., Yuste, I., González‐Burgos, E., & Serrano, D. R. (2025) · Bioprinting · doi:10.1016/j.bprint.2025.e00394 · Cited by 28 · see citing works
Organoids as models of immune-organ interaction
Harter, M. F., Recaldin, T., & Gjorevski, N. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116214 · Cited by 31 · see citing works
Alternative experimental approaches to reduce animal use in biomedical studies
Lee, S. Y., Lee, D. Y., Kang, J. H., Jeong, J. W., Kim, J. H., Kim, H. W., Oh, D. H., Kim, J., Rhim, S., Kim, G., et al. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103131 · Cited by 30 · see citing works
Engineered Human Organoids for Biomedical Applications
Zhu, Y., Sun, L., Wu, X., Gu, Z., & Zhao, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202310961 · Cited by 27 · see citing works
Mimicking Tumor Metastasis Using a Transwell‐Integrated Organoids‐On‐a‐Chip Platform
Chen, M., Han, S., Tao, Q., Hu, R., Sun, Q., Zheng, M., Chen, Z., Lin, Q., Yin, M., Zhao, S., et al. (2024) · Small · doi:10.1002/smll.202308525 · Cited by 25 · see citing works
Challenges in validation of combination treatment strategies for CRC using patient-derived organoids
Benboubker, V., Ramzy, G. M., Jacobs, S., & Nowak-Sliwinska, P. M. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03173-x · Cited by 28 · see citing works
“The engineering behind organoid on-chip models is challenging and still need improvement for standardization of the method for robust reproducibility but it unlocks new avenues of research by using models that are closer to in vivo [96].”
MethodNi, B., Ye, L., Zhang, Y., Hu, S., & Lei, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06381-x · Cited by 25 · see citing works
“Humanoid organoid models facilitate macroscopic and microscopic analyses of intercellular crosstalk, resulting in multi-organ models that effectively simulate complex tissue-tissue and inter-organ communications, making them suitable for organ development, toxicity, and efficacy [41].”
Microfluidic-based human prostate-cancer-on-chip
Jiang, L., Khawaja, H., Tahsin, S., Clarkson, T. A., Miranti, C. K., & Zohar, Y. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1302223 · Cited by 26 · see citing works
A generic pump‐free organ‐on‐a‐chip platform for assessment of intestinal drug absorption
Guo, Y., Xie, Y., & Qin, J. (2024) · Biotechnology Journal · doi:10.1002/biot.202300390 · Cited by 23 · see citing works
Membrane-based microfluidic systems for medical and biological applications
Calzuola, S. T., Newman, G., Feaugas, T., Perrault, C. M., Blondé, J.-B., Roy, E., Porrini, C., Stojanović, G. M., & Vidić, J. (2024) · Lab on a Chip · doi:10.1039/d4lc00251b · Cited by 22 · see citing works
Baldassarri, I., Tavakol, D. N., Graney, P. L., Chramiec, A. G., Hibshoosh, H. H., & Vunjak‐Novakovic, G. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2405257121 · Cited by 23 · see citing works
“The complexity of an OOC is dictated by the proposed research question, with flexibility to enable the deconstruction of microenvironmental and cellular contributions to cancer progression ( 16 , 17 , 20 , 21 , 27 ).”
Self-citationElfatimi, E., Lekbach, Y., Prakash, S., Karan, S., Dorotta, J. C., Garcia, A., Suoth, B. S., Maurya, C., Omorogieva, E., Ng, S. X. L., et al. (2025) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2025.1681106 · Cited by 25 · see citing works
de Janon, A., Mantalaris, A., & Panoskaltsis, N. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200836 · Cited by 25 · see citing works
Boosting the Clinical Translation of Organ-on-a-Chip Technology
Caballero, D., Reis, R. L., & Kundu, S. C. (2022) · Bioengineering · doi:10.3390/bioengineering9100549 · Cited by 23 · see citing works
“To promote its adoption by the clinic as a regular screening tool, academic and industrial developers must adapt this technology to clinical practitioners to perform more efficient, simpler, reliable, robust and rapid diagnostic/screening tests, enhancing their compatibility with current medical technologies [66].”
MethodModeling and countering the effects of cosmic radiation using bioengineered human tissues
Tavakol, D. N., Nash, T. R., Kim, Y., He, S., Fleischer, S., Graney, P. L., Brown, J. A., Liberman, M., Tamargo, M. A., Harken, A. D., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122267 · Cited by 23 · see citing works
Self-citationDeveloping 3D bioprinting for organs-on-chips
Wu, Z., Liu, R., Shao, N., & Zhao, Y. (2025) · Lab on a Chip · doi:10.1039/d4lc00769g · Cited by 23 · see citing works
Toward continuous monitoring systems: emerging trends of on-chip sensors in organ-on-a-chip
Ling, S., Xu, C., Jiang, Y., Xu, F., Jin, H., Chen, H. H., Chen, S., Ding, Z., & Sun, D. (2026) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-01142-8 · Cited by 24 · see citing works
“Its emergence represents a transformative advancement in biomedical research, with profound signi fi cance for multiple domains, spanning basic life science, preclinical drug development, and personalized medicine 2 .”
Endodontic Tissue Regeneration: A Review for Tissue Engineers and Dentists
Astudillo-Ortiz, E., Babo, P., Sunde, P. T., Galler, K., Gómez-Florit, M., & Gomes, M. (2023) · Tissue engineering. Part B, Reviews · doi:10.1089/ten.teb.2022.0211 · Cited by 15 · see citing works
“209 Among these, the dentin–pulp interface has been recreated with a design comprising two microfluidic channels separated by a dentin fragment.”
Progress of organoid platform in cardiovascular research
Du, X., Jia, H., Chang, Y., Zhao, Y., & Song, J. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.05.043 · Cited by 21 · see citing works
“…through vascular perfusion to influence each tissue (increasing its fidelity by cell continuation in a tissue-like environment in the body) as well as the entire multi-organ model (by providing system components such as metabolism, immunity, and clearing needed for physiological studies) [194].”
BackgroundTrapečar, M. (2021) · FEBS Letters · doi:10.1002/1873-3468.14260 · Cited by 21 · see citing works
Makarczyk, M. J., Hines, S. E., Yagi, H., Li, Z. A., Aguglia, A. M., Zbikowski, J., Padget, A.-M., Gao, Q., Bunnell, B. A., Goodman, S. B., et al. (2023) · Biomolecules · doi:10.3390/biom13020384 · Cited by 20 · see citing works
3D free-assembly modular microfluidics inspired by movable type printing
Huang, S., Wu, J., Zheng, L., Long, Y., Chen, J., Li, J., Dai, B., Lin, F., Zhuang, S., & Zhang, D. (2023) · Microsystems & Nanoengineering · doi:10.1038/s41378-023-00585-1 · Cited by 20 · see citing works
“The extraordinary features of 3D-FAMM are as follows: (1) flexibility in the construction of all-inone microfluidic systems; (2) reusability of modular molds and attachments; (3) wide selection of materials with biochemical compatibility and optical transparency; (4) standardization of size and interconnection and sta…”
MethodTrends in organ-on-a-chip for pharmacological analysis
Xu, X., Cheung, S., Jia, X., Fan, G., Ai, Y., Zhang, Y., & Liang, Q. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117905 · Cited by 20 · see citing works
From “organs on a chip” to “patient on a chip”
Saiding, Q., Ma, J., Ke, C., & Cui, W. (2022) · The Innovation · doi:10.1016/j.xinn.2022.100282 · Cited by 19 · see citing works
“Organ communication on the chip provides better emulation of disease development in living tissues.(5) Gene Ontology analysis showed that all connected tissues maintained their phenotypes and function stability during the 4 weeks of maturation, contributing a more solid basis for the subsequent pharmacokinetics/pharma…”
BackgroundReagent‐Free Covalent Immobilization of Biomolecules in a Microfluidic Organ‐On‐A‐Chip
Ashok, D., Singh, J., Jiang, S., Waterhouse, A., & Bilek, M. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202313664 · Cited by 19 · see citing works
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1462293 · Cited by 19 · see citing works
Microphysiological Neurovascular Barriers to Model the Inner Retinal Microvasculature
Maurissen, T. L., Pavlou, G., Bichsel, C. A., Villaseñor, R., Kamm, R. D., & Ragelle, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020148 · Cited by 19 · see citing works
“Resulting MPS now facilitate the formation, maturation and maintenance of complex organotypic structures in well-defined and customizable microenvironments [18,21,22].”
BackgroundMansouri, M., Ahmed, A., Ahmad, S. D., McCloskey, M. C., Joshi, I. M., Gaborski, T. R., Waugh, R. E., McGrath, J. L., Day, S. W., & Abhyankar, V. V. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202200802 · Cited by 19 · see citing works
Next-generation engineered microsystems for cell biology: a systems-level roadmap
Sundaram, S., & Chen, C. S. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.01.003 · Cited by 17 · see citing works
Wu, D., Wu, J., Liu, H., Shi, S., Wang, L., Huang, Y., Yu, X., Lei, Z., Ouyang, T., Shen, J. Y., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00393k · Cited by 17 · see citing works
Howe, K., Cybulsky, M., & Fish, J. E. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.888390 · Cited by 16 · see citing works
“In this way, we may need to move to organon-a-chip methods (143) to better elucidate the ideal endothelial communication strategy we wish to either boost or interrupt.”
MethodBiomimetic cell culture for cell adhesive propagation for tissue engineering strategies
Luo, Q., Shang, K., Zhu, J. F., Wu, Z., Cao, T., Ahmed, A. A. Q., Huang, C., & Xiao, L. J. (2023) · Materials Horizons · doi:10.1039/d3mh00849e · Cited by 17 · see citing works
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer
Campisi, M., Osaki, T., Dryg, I., Stornante, C., Wolff, J., Weirather, J. L., Weaver, N. C., Tarannum, M., Gillanders, I., Bers, A. E., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.02.008 · Cited by 16 · see citing works
Bokhari, R. S., Beheshti, A., Blutt, S. E., Bowles, D. E., Brenner, D., Britton, R. A., Bronk, L. F., Cao, X., Chatterjee, A., Clay, D. E., et al. (2022) · Life Sciences in Space Research · doi:10.1016/j.lssr.2022.08.003 · Cited by 15 · see citing works
Self-citationAdvancement of organ-on-chip towards next generation medical technology
Singh, G., Mishra, A., Mathur, A. K., Shastri, S., Nizam, A., Rizwan, A., Dadial, A. S., Firdous, A., & Hassan, H. (2024) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2024.100480 · Cited by 16 · see citing works
Opportunities for Microphysiological Systems in Toxicity Testing of New Drug Modalities
Maulana, T. I., Wevers, N. R., Kristoforus, T., Chandler, M. R., Lanz, H. L., Joore, J., Vulto, P., Villenave, R., Kustermann, S., Loskill, P., et al. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061724-080621 · Cited by 18 · see citing works
Garcia, M. I., Dame, K., Charwat, V., Siemons, B. A., Finsberg, H. N. T., Bhardwaj, B., Yokosawa, R., Goswami, I., Bruckner, D., Wall, S., et al. (2025) · Nature Protocols · doi:10.1038/s41596-025-01166-4 · Cited by 14 · see citing works
Building Blood Vessel Chips with Enhanced Physiological Relevance
Mu, X., Gerhard‐Herman, M. D., & Zhang, Y. S. (2023) · Advanced Materials Technologies · doi:10.1002/admt.202201778 · Cited by 14 · see citing works
Innovative engineering approaches to model host-microbiome interactions in vitro
Azamar, K. M. M., Sudi, S. D., Mohammadalizadeh, Z., Coffin, C., Parker, I., & Porras, A. M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115677 · Cited by 12 · see citing works
Complex or not too complex? One size does not fit all in next generation microphysiological systems
Bersini, S., Arrigoni, C., Talò, G., Candrian, C., & Moretti, M. (2024) · iScience · doi:10.1016/j.isci.2024.109199 · Cited by 12 · see citing works
“…these two opposite approaches, holding the promise to fully mimic the functional tissue units of an entire human organ at a micro-to meso-scale 4 and thus representing a half-way entity between the defined but simplistic in vitro models and the comprehensive but not fully controllable in vivo…”
BackgroundA synoptic examination of commercially viable nanofiber-based products
Chaudhari, D. R., Vinod, R., Shah, D. P., Vaishnav, D. J., & Kapoor, D. U. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106323 · Cited by 13 · see citing works
Bai, H., Olson, K. N. P., Pan, M., Marshall, T., Singh, H., Ma, J., Gilbride, P., Yuan, Y., McCormack, J., Si, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202304332 · Cited by 11 · see citing works
A similarity scaling approach for organ-on-chip devices
Feng, J. J., & Hedtrich, S. (2022) · Lab on a Chip · doi:10.1039/d2lc00641c · Cited by 13 · see citing works
Crosstalk between kidney and bones: New perspective for modulating osteoporosis
Duan, Y., Zhao, L., Lu, Y., Li, J., & Li, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102776 · Cited by 16 · see citing works
Experimental models of pancreas cancer: what has been the impact for precision medicine?
Pantazopoulou, V., Kubota, C. S., Ogawa, S., Gulay, K. C. M., Lin, X., Song, H., Weitz, J., Tiriac, H., Lowy, A. M., & Engle, D. D. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191945 · Cited by 13 · see citing works
“These models can be leveraged for drug screening and targeted therapy approaches (75, 76).”
Cadavid, J. L., Li, N. T., & McGuigan, A. P. (2024) · Biophysics Reviews · doi:10.1063/5.0179125 · Cited by 11 · see citing works
Liao, Y., Chai, D., Wang, Q., Wang, X., Yong, Q., Cheng, Z., Zhang, C., Zhang, D., Liu, B., Liu, R., et al. (2024) · Materials Horizons · doi:10.1039/d4mh01174k · Cited by 12 · see citing works
A micro-lung chip with macrophages for targeted anti-fibrotic therapy
Xia, J., Dong, R., Fang, Y., Guo, J., Xiong, Z., Zhang, T., & Sun, W. (2025) · Biofabrication · doi:10.1088/1758-5090/adb338 · Cited by 12 · see citing works
“The establishment of in vitro biomimetic organ chips should be based on both the normal functional units of tissues and pathological characteristics of the target disease [24, 25].”
Musculoskeletal organoids-on-chip uncover muscle–bone communication under intermittent hypoxia
Tong, X., Liu, M., Li, J., Zhang, W., Hu, R. J., Yang, G., Deng, J., Li, Y., Li, X., & Liu, Y. (2025) · National Science Review · doi:10.1093/nsr/nwaf214 · Cited by 12 · see citing works
“Organoid technology and organoids-on-chip (OoC) engineering have pioneered the spatio-temporal construction and modeling of native microscale tissue architecture [8 ], enabling personalized medicine [9 ].”
- Authors
- Vunjak-Novakovic, G., Ronaldson-Bouchard, K., & Radisic, M.
- Affiliations
- Columbia University (US)
- University of Toronto (CA)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 184
- Issue
- 18
- Pages
- 4597-4611
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC8417425
- OpenAlex
- W3197954209
- Cited by
- 248
- References
- 110
- Citations by year
- 2026: 45 · 2025: 54 · 2024: 64 · 2023: 41 · 2022: 39 · 2021: 5
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 366 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Natural Sciences and Engineering Research Council of Canada (RGPIN 326982-10)
- Canadian Institutes of Health Research (FDN-167274)
- National Institutes of Health (UH3 EB025765, CA249799, P41 EB027062, 3R01 HL076485)
- National Aeronautics and Space Administration (NNX16AO69A, CHRP 493737-16)
- National Science Foundation (NSF16478)
- Canada Research Chairs
- NSF
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- organ-on-a-chip, organoids, tissue engineering, model validation
- MeSH terms
- Animals, Humans, Models, Biological, Research, Tissue Engineering, Lab-On-A-Chip Devices, Cellular Microenvironment, Cell Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review